AN ANTONIO—Adding a wearable neuromodulation therapy device (Cala Trio, Cala Health) improved tremor in patients suffering from essential tremor, according to an interim analysis of a prospective, randomized controlled study (ClinicalTrials.gov Identifier: NCT05540626), presented at AMCP 2023 (presentation G15).
study met its primary end point, demonstrating patients adding transcutaneous afferent patterned stimulation (TAPS) therapy saw significantly reduced (i.e., improved) tremor power